Ontology highlight
ABSTRACT: Importance
Immune suppression discontinuation is routinely attempted after allogeneic hematopoietic cell transplantation (HCT) and under current practices may lead to graft-vs-host disease (GVHD)-associated morbidity and death. However, the likelihood and predictive factors associated with successful immune suppression discontinuation after HCT are poorly understood.Objectives
To examine factors associated with successful immune suppression discontinuation and risk for immune suppression discontinuation failure under conventional HCT approaches and develop a practical tool to estimate successful immune suppression discontinuation likelihood at the clinical point of care.Design, setting, and participants
Using long-term follow-up data from 2 national Blood and Marrow
SUBMITTER: Pidala J
PROVIDER: S-EPMC6763979 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature